Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x100px
Organisation › Details

Kriya Therapeutics (Group)

Kriya is a fully integrated company pioneering novel technologies and therapeutics in gene therapy. The company aims to revolutionize how gene therapies are designed, developed, and manufactured, improving speed to market and delivering significant reductions in cost. The company is advancing a deep and diversified pipeline of innovative gene therapies in multiple therapeutic area divisions, with current pipeline programs in metabolic disorders, neurology and ophthalmology. Kriya is backed by leading life sciences and technology investors, and has core operations in Silicon Valley, California and Research Triangle Park, North Carolina. *


Period Start 2019-12-31 established (approx)
  Today Kriya Therapeutics Inc.
Products Industry gene therapy
  Industry 2 adeno-associated viral vector (AAV vector)
Person Person Ramaswamy, Shankar (Kriya Therapeutics 2019Q4– CEO + Co-Founder before Roivant/Axovant)
Region Region Redwood City, CA
  Country United States (USA)
  Street 1100 Island Drive
Suite 203
  City 94065 Redwood City, CA
    Address record changed: 2022-11-21
Basic data Employees n. a.
    * Document for »About Section«: Kriya Therapeutics, Inc.. (11/16/22). "Press Release: Kriya Acquires Redpin Therapeutics, Adding Neurology Pipeline to Gene Therapy Portfolio". Redwood City, CA & Research Triangle Park, NC.
Record changed: 2023-07-10


Picture [iito] [LSE] Business Portal 650x200px

More documents for Kriya Therapeutics (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x300px

» top